Santhera Expands Agamree Distribution Partnership with Biomedica Across Five Additional Markets
Santhera Pharmaceuticals has expanded its exclusive distribution partnership with Biomedica to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, extending access to Agamree (vamorolone) for patients with Duchenne muscular dystrophy across additional underserved markets.
Corticosteroid Therapy | 14/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy